Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease

A Heidenreich, D Pfister - Current opinion in urology, 2020 - journals.lww.com
Patients with low-volume/low-risk metastatic prostate cancer (mPCA), good response to
neoadjuvant androgen deprivation therapy and a good Eastern Cooperative Onology Group …
被引用次数：28 相关文章

Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.

A Heidenreich, D Pfister - Current Opinion in Urology, 2020 - europepmc.org
Patients with low-volume/low-risk metastatic prostate cancer (mPCA), good response to
neoadjuvant androgen deprivation therapy and a good Eastern Cooperative Onology Group …

Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease

A Heidenreich, D Pfister - Curr. Opin. Urol., 2020 - kups.ub.uni-koeln.de
Purpose of review Local treatment of the primary by either radical prostatectomy or radiation
therapy is discussed controversially. The role of cytoreductive radical prostatectomy has …

Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease

A Heidenreich, D Pfister - Current opinion in urology, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose of review Local treatment of the primary by either radical prostatectomy or radiation
therapy is discussed controversially. The role of cytoreductive radical prostatectomy has …

Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease

A Heidenreich, D Pfister - Curr. Opin. Urol., 2020 - kups.ub.uni-koeln.de
Purpose of review Local treatment of the primary by either radical prostatectomy or radiation
therapy is discussed controversially. The role of cytoreductive radical prostatectomy has …